Skip to content

Biofeedback Gait Training on Gait Quality in Stroke

Effects of Biofeedback Gait Training on Gait Quality Post-stroke

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06490276
Enrollment
40
Registered
2024-07-08
Start date
2024-10-01
Completion date
2027-12-31
Last updated
2025-02-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke

Keywords

Biofeedback, Gait symmetry, Gait variability, Gait training

Brief summary

Post-stroke gait dysfunction is characterized by reduced gait velocity and stride length, along with gait asymmetry and instability. Gait asymmetry and instability are considered as indicators for gait quality, which affect independence and quality of life in individual with stroke. Previous studies have suggested that gait biofeedback is a promising strategy for enhancing the efficacy of post-stroke gait training. However, there is insufficient evidence on the effects of kinematic biofeedback gait training on gait asymmetry and instability in individuals with stroke. Therefore, the purpose of this study is to investigate the effects of real-time kinematic gait biofeedback training on gait quality in individuals with stroke.

Interventions

Gait training include treadmill and overground walking. The biofeedback device system will provide real-time feedback on hip extension angles.

Gait training include treadmill and overground walking.

Sponsors

National Yang Ming Chiao Tung University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
20 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* First stroke * Stroke onset time ≥ 6 months * Functional Ambulation Category ≥3 * Passive range of motion of affected hip extension is at least 10 degrees * Mini-Mental State Measurement score ≥ 24 points

Exclusion criteria

* Modified Ashworth Scale of affected ankle plantar flexors ≥ 2 * Muscle strength of affected ankle plantar flexors via Manual Muscle Testing ≤ 1 * Uncorrected auditory impairment * Severe cardiovascular disease or uncontrolled hypertension * Other orthopedic diseases that may affect walking ability * Other neurological disease except stroke

Design outcomes

Primary

MeasureTime frameDescription
Gait symmetryChange from baseline at 4 weeks after training and 4 weeks follow-upUsing GAITRite system to measure the symmetry of saptiotemporal parameters
Gait variabilityChange from baseline at 4 weeks after training and 4 weeks follow-upUsing GAITRite system to measure the coefficient of variation of saptiotemporal parameters

Secondary

MeasureTime frameDescription
Berg Balance ScaleChange from baseline at 4 weeks after training and 4 weeks follow-upUsing Berg Balance Scale to evaluate balance ability
Activities-specific Balance Confidence ScaleChange from baseline at 4 weeks after training and 4 weeks follow-upUsing Activities-specific Balance Confidence Scale to evaluate individual's balance confidence in performing daily activities
Propulsive forceChange from baseline at 4 weeks after training and 4 weeks follow-upUsing Force plate to measure the ground reaction force
Frenchay Activities IndexChange from baseline at 4 weeks after training and 4 weeks follow-upUsing Frenchay Activities Index to measure individual's capacity to perform instrumental activities of daily living
Stroke Impact ScaleChange from baseline at 4 weeks after training and 4 weeks follow-upUsing Stroke Impact Scale to evaluate disability and quality of life after stroke
Taiwan Chinese version Falls Efficacy ScaleChange from baseline at 4 weeks after training and 4 weeks follow-upUsing Taiwan Chinese version Falls Efficacy Scale to evaluate concerns about falling
Gait performanceChange from baseline at 4 weeks after training and 4 weeks follow-upUsing the GAITRite system to evaluate saptiotemporal parameters

Countries

Taiwan

Contacts

Primary ContactYea-Ru Yang, PhD
yryang@nycu.edu.tw+886228267279

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026